27-MAR-1987 12:12:51.13&#5;&#5;&#5;F

<PRAXIS BIOLOGICS INC> MAKES INITIAL STOCK SALE

Praxis Biologics Inc said it began its initial public common stock offering of 1,750,000 shares at 15.50 dlrs a share.     The company said proceeds of the offering will be used to fund product research and development, including clinical testing.     It said the money will also be used to cover acquisition, construction and equipment costs and for working capital.     The offering is being managed by Shearson Lehman Bros Inc and Merrill Lynch Capital Markets, the company said.  Reuter &#3;

